Author: Brandon Malone; Boris Simovski; Clement Moline; Jun Cheng; Marius Gheorghe; Hugues Fontenelle; Ioannis Vardaxis; Simen Tennoe; Jenny-Ann Malmberg; Richard Stratford; Trevor Clancy
Title: Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2: toward universal blueprints for vaccine designs Document date: 2020_4_21
ID: cm30gyd8_29
Snippet: Although an early report in a preprint article demonstrated in a few sequences that the SARS-COV-2 genome has a lower mutation rate and genetic diversity compared to that of SARS-COV [34] , another preprint study has demonstrated that there are evolving genetic patterns emerging in different strains of SARS-COV-2 in diverse geographic locations [35] . A universal vaccine blueprint should ideally also be able to protect populations against differe.....
Document: Although an early report in a preprint article demonstrated in a few sequences that the SARS-COV-2 genome has a lower mutation rate and genetic diversity compared to that of SARS-COV [34] , another preprint study has demonstrated that there are evolving genetic patterns emerging in different strains of SARS-COV-2 in diverse geographic locations [35] . A universal vaccine blueprint should ideally also be able to protect populations against different emerging clades of the SARS-COV-2 virus and we therefore compared the AP potential of approximately 3400 virus sequences in the GISAID database against the AP potential of the Wuhan Genbank reference sequence. The outcome of that comparison is illustrated in Figure 4 , and hints at a trend whereby SARS-COV-2 mutations seem to reduce their potential to be presented and consequently detected by the host immune system. Similar trends have been observed in chronic infections such as HPV and HIV.
Search related documents:
Co phrase search for related documents- potential reduce and SARS genome: 1, 2, 3, 4, 5
- reference sequence and SARS genome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
- reference sequence and SARS mutation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- reference sequence and SARS virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- reference sequence and similar trend: 1
- reference sequence and universal vaccine: 1
- reference sequence and virus sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- reference sequence and Wuhan Genbank reference sequence: 1
- SARS genome and similar trend: 1
- SARS genome and universal vaccine: 1, 2, 3, 4
- SARS genome and virus sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55
- SARS mutation and universal vaccine: 1, 2
- SARS mutation and virus sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9
- SARS mutation and Wuhan Genbank reference sequence: 1
- SARS virus and similar trend: 1, 2, 3, 4
- SARS virus and universal vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- SARS virus and virus sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- SARS virus and Wuhan Genbank reference sequence: 1
- universal vaccine and virus sequence: 1
Co phrase search for related documents, hyperlinks ordered by date